Developing LC–MS/MS methods to quantify rivaroxabanin human plasma and urine: application to therapeuticdrug monitoring
2004 ◽
Vol 1058
(1-2)
◽
pp. 163-168
◽
1983 ◽
Vol 275
◽
pp. 432-435
◽
Keyword(s):
2014 ◽
Vol 99
◽
pp. 67-73
◽
1985 ◽
Vol 339
◽
pp. 359-365
◽
1985 ◽
Vol 60
(6)
◽
pp. 1166-1173
◽
2005 ◽
Vol 828
(1-2)
◽
pp. 41-54
◽
Keyword(s):